Clinical trialNCT07659652Not, yet, recruitingObservational

Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease

SponsorUniversity of California, San FranciscoEnrollment200Brain Metastases From Breast CancerBreast Cancer, MetastaticBreast Cancer, Metastatic Breast CancerBreast Cancer, Quality of LifeLeptomeningeal Metastasis of Breast Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Central nervous system (CNS) metastases including breast cancer brain metastases (BCBMs) and leptomeningeal disease (LMD) are common affecting up to 30% of patients with metastatic breast cancer (MBC). The goal of this research is to understand symptom burden and quality of life trajectories in this population and how treatments guide care management decisions.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Laura Huppert, MD
University of California, San Francisco
Principal Investigator
clinicaltrials.gov ↗
Michelle Melisko, MD
University of California, San Francisco
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, San Francisco
San Francisco, California, United States
Laura Huppert, MDMichelle Melisko, MD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Jun 2026
Primary completion: 31 Dec 2030
Completion: 31 Dec 2035
Last update posted: 22 Jun 2026
Registered enrollment: 200
Registry id: NCT07659652

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.